[Antiparkinson agents. 50].
D001285:Atropine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D008615:Mephenesin; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy*; D010640:Phenothiazines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011736:Pyridoxine / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D010640:Phenothiazines; D004295:Dihydroxyphenylalanine; D008615:Mephenesin; D001285:Atropine; D004155:Diphenhydramine; D011433:Propranolol; D012601:Scopolamine; D011736:Pyridoxine; D009526:Nialamide
Antiparkinsonika. 50.